Journal report of the Clinical Trials on Alzheimer's Disease (CTAD) 2018 conference, including part of the research that I presented during that conference.
The reports summaries three studies on how the recently proposed NIA-AA framework for defining Alzheimer's disease measures op again real data. These studies have attemped to apply the framework criteria on existing cohorts, to group individuals in diffferent stages of clinical severity, track decline over time and predict future progression.
19 Nov 2018
How Does The NIA-AA Framework Measure Up Against Real Data?